Lannett Company, Inc. (AMEX:LCI)

CAPS Rating: 3 out of 5

The Company develops, manufactures, markets and distributes generic versions of pharmaceutical products.

Recs

0
Player Avatar worknhard (< 20) Submitted: 1/30/2012 10:30:15 AM : Outperform Start Price: $4.89 LCI Score: -17.49

FDA approvals opened up after 483's were fixed.Backlog of approvals to comeCody labs starting to hit stride and provide profits.

Featured Broker Partners


Advertisement